COc1cc([C@@H]2c3cc4c(cc3[C@@H](OC(=O)c3cccc(N)c3)C3COC(=O)[C@@H]32)OCO4)cc(OC)c1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?